Author
Listed:
- Chen Wang
(University of Geneva)
- Coline Barnoud
(University of Geneva)
- Mara Cenerenti
(University of Geneva
Ludwig Institute for Cancer Research)
- Mengzhu Sun
(University of Geneva)
- Irene Caffa
(University of Genoa)
- Burak Kizil
(University of Geneva)
- Ruben Bill
(University of Geneva
AGORA Cancer Research Center
Massachusetts General Hospital and Harvard Medical School)
- Yuanlong Liu
(University of Lausanne
Swiss Cancer Center Leman
Swiss Institute of Bioinformatics (SIB))
- Robert Pick
(University of Geneva)
- Laure Garnier
(University of Geneva)
- Olga A. Gkountidi
(University of Geneva)
- Louise M. Ince
(University of Geneva)
- Stephan Holtkamp
(Ludwig-Maximilians-Universität Munich)
- Nadine Fournier
(Swiss Institute of Bioinformatics (SIB))
- Olivier Michielin
(AGORA Cancer Research Center)
- Daniel E. Speiser
(University of Lausanne)
- Stéphanie Hugues
(University of Geneva
Geneva Centre for Inflammation Research)
- Alessio Nencioni
(University of Genoa
IRCCS Ospedale Policlinico San Martino)
- Mikaël J. Pittet
(University of Geneva
Ludwig Institute for Cancer Research
AGORA Cancer Research Center
Massachusetts General Hospital and Harvard Medical School)
- Camilla Jandus
(University of Geneva
Ludwig Institute for Cancer Research
Geneva Centre for Inflammation Research)
- Christoph Scheiermann
(University of Geneva
Ludwig-Maximilians-Universität Munich
Geneva Centre for Inflammation Research)
Abstract
The process of cancer immunosurveillance is a mechanism of tumour suppression that can protect the host from cancer development throughout its lifetime1,2. However, it is unknown whether the effectiveness of cancer immunosurveillance fluctuates over a single day. Here we demonstrate that the initial time of day of tumour engraftment dictates the ensuing tumour size across mouse cancer models. Using immunodeficient mice as well as mice lacking lineage-specific circadian functions, we show that dendritic cells (DCs) and CD8+ T cells exert circadian anti-tumour functions that control melanoma volume. Specifically, we find that rhythmic trafficking of DCs to the tumour draining lymph node governs a circadian response of tumour-antigen-specific CD8+ T cells that is dependent on the circadian expression of the co-stimulatory molecule CD80. As a consequence, cancer immunotherapy is more effective when synchronized with DC functions, shows circadian outcomes in mice and suggests similar effects in humans. These data demonstrate that the circadian rhythms of anti-tumour immune components are not only critical for controlling tumour size but can also be of therapeutic relevance.
Suggested Citation
Chen Wang & Coline Barnoud & Mara Cenerenti & Mengzhu Sun & Irene Caffa & Burak Kizil & Ruben Bill & Yuanlong Liu & Robert Pick & Laure Garnier & Olga A. Gkountidi & Louise M. Ince & Stephan Holtkamp , 2023.
"Dendritic cells direct circadian anti-tumour immune responses,"
Nature, Nature, vol. 614(7946), pages 136-143, February.
Handle:
RePEc:nat:nature:v:614:y:2023:i:7946:d:10.1038_s41586-022-05605-0
DOI: 10.1038/s41586-022-05605-0
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:614:y:2023:i:7946:d:10.1038_s41586-022-05605-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.